Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Letrozole for Recurrent UPSC
NCT03285802Phase 3Completed
- Sponsor
- Greater Baltimore Medical Center
- Start
- Sep 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in uterine papillary serous carcinoma (UPSC), sponsored by Greater Baltimore Medical Center. Started Sep 2017; status: completed.
02
Drugs
everolimus
03
Conditions
uterine papillary serous carcinoma (UPSC)
Beyond the preview
Go deeper on NCT03285802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03285802.